Related Experiment Video
Updated: Jul 2, 2025
06:57
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
Published on: February 12, 2021
3.2K
Cardiorespiratory optimal point in post-COVID-19 patients: a cross-sectional study
Karinne Simões da Cruz Santos1, Gabriela Menezes Gonçalves de Brito1, Enaldo Vieira de Melo2
1Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil.
Revista Do Instituto De Medicina Tropical De Sao Paulo
|February 21, 2024
Summary
Cardiopulmonary Exercise Testing revealed altered cardiorespiratory optimal point (COP) in post-COVID-19 patients, particularly those with severe initial infections. This finding highlights the need for ongoing cardiorespiratory monitoring in long-COVID recovery.
Area of Science:
- Cardiology
- Pulmonology
- Infectious Diseases
Background:
- Long-COVID, or post-COVID-19 syndrome, presents diverse long-term health challenges.
- Cardiorespiratory optimal point (COP) from Cardiopulmonary Exercise Testing (CPET) is vital for assessing post-COVID-19 functional capacity and detecting anomalies.
Purpose of the Study:
- To evaluate COP values in post-COVID-19 patients.
- To categorize patients based on initial COVID-19 severity (mild, moderate, severe).
Main Methods:
- A cross-sectional study involving 80 post-SARS-CoV-2 infected patients in Northeast Brazil.
- Patients underwent CPET, with COP and other cardiorespiratory metrics assessed.
- Clinical stratification into mild, moderate, and severe COVID-19 groups.
Main Results:
- Significant differences in predicted COP were observed between mild and severe COVID-19 groups (p=0.042).
- Moderate and severe COVID-19 survivors exhibited average COP values above 22.
- No significant differences in respiratory exchange ratio, heart rate, or oxygen uptake efficiency slope were found across groups.
Conclusions:
- Altered COP values in severe COVID-19 survivors suggest potential cardiovascular and respiratory system integration issues.
- Continuous cardiorespiratory monitoring is crucial for post-COVID-19 patients.
- Further research is warranted to explore the prognostic implications of elevated COP in post-severe COVID-19.
More Related Videos
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:21Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
01:30Acute Respiratory Failure-III
185
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
185
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K